VESTAVIA HILLS, Ala., Sept. 11 /PRNewswire/ -- ALtruis (www.altruis.com ), an e-commerce company focusing on healthcare and biomedical research, announced the launch of the ALtruis Biomedical Network(SM) (ABN). The ABN (www.altruisbiomedical.net ) consists of a novel business model and ca. 1,000 registered Internet domain names, which help drive high volume traffic to numerous specialized healthcare Websites operated by ALtruis. This new hierarchical e-business Webring system provides to Internet visitors quality information (content) on various healthcare topics, coupled to relevant advertisements for products and services from vendors. The ABN operates multiple topic-specific Websites in a broad range of categories, such as skincare, women's health, oncology, fitness, and biotechnology research and development. According to Thomas P. Dooley, Ph.D., the CEO and inventor -- "Our Websites are linked together like numerous grape clusters on a large vine, with each Website covering individual healthcare and research categories. The hundreds of links within the ALtruis Biomedical Network can drive high volume Internet traffic through a proprietary method, with seamless access to virtually any healthcare topic of interest." From a business perspective, this new e-business model has many advantages over other potential e-commerce competitors, who typically operate a single Website. Most potential competitors are facing challenges generating sufficient revenues to justify their high valuations, market caps, and capital burn rates. Unlike them, the ABN is scalable, which permits incremental increases in the number of offered topic-specific Websites, perhaps exceeding 100 within a year. Furthermore, this patent-pending e-business model complements conventional bricks and mortar companies, such as pharmaceutical companies and retailers, and helps them present advertisements to a large captive Internet audience with genuine interest in the selected topics. Over the past month, the company has already launched dozens of ABN Websites. Examples of the new Websites and topic areas include: EarthDerm.com -- dermatology and skincare Cancer-Drug.com -- oncology Allergy-Drug.com -- inflammation and allergy JockRash.com -- fitness and nutrition Anti-Biotic.com -- infectious diseases e-WomensHealth.net -- gynecology and breasts DNA-Arrays.com -- genome research ALtruis LLC is a privately held company in Vestavia Hills, Alabama, established by successful scientist-entrepreneurs with altruistic intentions. ALtruis commenced operations in January 1999, and anticipates being profitable within 2 years based on revenues from advertising and partners. Both ALtruis and IntegriDerm, Inc. (www.integriderm.com ) were co-founded by Dr. Dooley and Jim Hudson, the founder of Research Genetics, Inc., a leader in products to the human genome research community and a subsidiary of Invitrogen Corp. ALtruis has a strategic alliance with IntegriDerm, which in turn has an alliance with Invitrogen / Research Genetics. Certain statements contained in this press release are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding profitability, benefits of association, product launches and company goals. Such forward- looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, but are not limited to delays or difficulties in obtaining sufficient revenues, or other legal or financial difficulties, as well as other risks and uncertainties.
SOURCE ALtruis LLC